|
|
|
LifeScienceHistory.com - Check us out on Instagram
New York Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New YorkLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Actinium Pharmaceuticals, Inc.
| | | Phone: | (646) 459-4201 | Year Established: | 2000 | Ticker: | ATNM | Exchange: | NYSE | Main Contact: | Sandesh Seth, CEO & Chairman | | Other Contacts: | Jehan Rowlands, Pharm.D., VP, Head of Regulatory Affairs Anil Kapur, CCO Steve O'Loughlin, Principal Financial and Accounting Officer Dale L. Ludwig, Ph.D., CSO Nitya Ray, Ph.D., Executive VP, Head of Product Development & Manufacturing Mark Berger, M.D., CMO Robert N. Daly, M.S., Ph.D., VP & Head of Clinical Operations
| | Company Description | Actinium Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing and commercializing targeted therapies for safer myeloablation and conditioning of the bone marrow prior to a bone marrow transplant and for the targeting and killing of cancer cells. | |
|
|
|
|
|